Sign In
Buy TXMD
$1.97
-0.0700 (-3.43%)
At Close: Jun 03, 2026
Here is why TherapeuticsMD jumped 300%
01:57pm, Tuesday, 31'st May 2022
TherapeuticsMD Inc. (NASDAQ: TXMD) surged 300% after the women's healthcare firm announced the signing of a definitive agreement to be purchased by an EW Healthcare Partners affiliate. EW Healthcare P
Why TherapeuticsMD Stock Is Soaring Today
10:12am, Tuesday, 31'st May 2022
TherapeuticsMD Inc (NASDAQ: TXMD) shares are surging Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners. E
Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market
06:11pm, Friday, 20'th May 2022
Are these biotech penny stocks on your watchlist right now? The post Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market appeared first on Penny Stocks to Buy, Picks, News and Information
Why TherapeuticsMD Shares Are Trading Higher Today
10:54am, Friday, 20'th May 2022
TherapeuticsMD Inc (NASDAQ: TXMD) shares are trading higher after FDA approved the supplemental application, including minor revisions to Annovera's in vitro release testing specification that all
TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q1 2022 Results - Earnings Call Transcript
08:07pm, Monday, 16'th May 2022
TherapeuticsMD, Inc. (NASDAQ:TXMD ) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Lisa Wilson - IR Hugh O'Dowd - CEO Michael Donegan - Interim CFO Mark Glickman - Chief
TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates
06:48pm, Monday, 16'th May 2022
TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -34.86% and 1.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022
04:05pm, Tuesday, 10'th May 2022
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its fir
TherapeuticsMD (TXMD) Stock: 1-For-50 Reverse Split Goes Into Effect
06:48am, Monday, 09'th May 2022
The TherapeuticsMD Inc (NASDAQ: TXMD) board has completed a 1-for-50 reverse stock split. These are the details.
Best Penny Stocks To Buy? 5 Explosive Stocks Under $1 To Watch Now
03:19pm, Wednesday, 23'rd Mar 2022
Penny Stocks Under $1 To Watch This Week. The post Best Penny Stocks To Buy?
TherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare Business
08:39am, Monday, 14'th Mar 2022
TherapeuticsMD had a rough 2021, and the share price shows it. The company battled the COVID-19 headwinds and has struggled to expand ANNOVERA's manufacturing.
TherapeuticsMD price target lowered at H.C. Wainwright on supply constraints
02:44pm, Friday, 11'th Mar 2022 Seeking Alpha
Citing the ongoing supply issues affecting a key product, H.C. Wainwright has trimmed the price target of the women’s healthcare company, TherapeuticsMD <> on Friday
TherapeuticsMD, Inc. 2021 Q4 - Results - Earnings Call Presentation
02:04pm, Friday, 11'th Mar 2022 Seeking Alpha
TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call Transcript
06:30pm, Thursday, 10'th Mar 2022 The Motley Fool
TXMD earnings call for the period ending December 31, 2021.
TherapeuticsMD, Inc. (TXMD) CEO Hugh O''Dowd On Q4 2021 Results - Earnings Call Transcript
03:35pm, Thursday, 10'th Mar 2022 Seeking Alpha
TherapeuticsMD: Q4 Earnings Insights
02:49pm, Thursday, 10'th Mar 2022 Benzinga
TherapeuticsMD (NASDAQ: TXMD ) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings TherapeuticsMD missed estimated earnings by 12.5%, reporting an EPS of $-0.09 versus an … Full story available on Benzinga.com
